1 Product identity
Ingredient risk
Contains a high-risk ingredient

DGL Plus Ginger

BrandAFI America's FinestBotanical Tablet or Pill 7 ingredients 1 high-risk 1 caution DSLD #81856
Net contents: 60 Chewable Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2018-02-23
2 Ingredients (7)
IngredientGroupSafety
granulated XylitolXylitolHigh risk
Microcrystalline CelluloseCellulose
GlycineGlycineGenerally Safe
Magnesium StearateMagnesiumUse with Caution
Carob powderCarob
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ High-risk ingredient — documented serious harm
Xylitol — Dog owner not warned about xylitol toxicity — potentially fatal to dogs [1]
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
GLA — Limited Evidence
⚠ May lower seizure threshold
⚠ Borage oil: hepatotoxic unless PA-free
Ginger Root — Limited Evidence
⚠ GI: heartburn at high doses
⚠ Antiplatelet effect
Xylitol — High risk
⚠ GI distress (gas, bloating, diarrhea) dose-dependent
⚠ Cardiovascular risk: 2023 Cleveland Clinic study linked xylitol to increased thrombotic events
Glycine — Generally Safe
⚠ Well tolerated
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID81856
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2018-02-23
6 More from AFI America's Finest
View AFI America's Finest Safety Scorecard → 15 products
Ashwagandha Root ExtractBeta 1,3 GlucanBioPerineCarnosineChrysinColeus Forskohlii
7 Cite this page
Vancouver
Pkhakadze G. DGL Plus Ginger — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 25]. Available from: https://supplement.ge/products/dgl-plus-ginger-81856/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG